BioMarin Pharmaceutical, Inc. (BMRN)

62.97 +0.05 (+0.08%) USD  |  NASDAQ  |  Feb 24, 15:30
More

BioMarin Pharmaceutical Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade